Explore the pharmacist's vital role in adverse event reporting for generic medications. Learn about regulatory duties, reporting barriers, and how pharmacovigilance ensures patient safety.
Read MoreTag: FAERS database
Adverse Event Reporting: Pharmacist Responsibility for Generic Medication Safety
Archive
Categories
Central Diabetes Insipidus and the Immune System: How They Interact
Learn how the immune system can trigger or worsen central diabetes insipidus, how to spot the link, diagnose it with labs and MRI, and treat both hormone loss and inflammation.
Mail-Order Generics: Real Benefits and Hidden Risks
Mail-order generics offer convenience and cost savings for chronic meds, but hidden risks like temperature damage, price markups, and safety gaps can threaten your health. Know the real trade-offs.
State Laws on NTI Substitution: Varying Requirements Across the US
State laws on NTI drug substitution vary widely across the U.S., with 27 states restricting generic swaps for medications like warfarin and levothyroxine. While the FDA says generics are safe, patient safety concerns are driving state-level rules - and a national shift is coming.
How to Address Allergies to Inactive Ingredients in Generics
Many people react to inactive ingredients in generic medications, not the active drug. Learn how lactose, gluten, dyes, and other fillers can trigger allergies - and what steps to take to stay safe.
How Ziprasidone Helps Reduce Hospitalizations for Mental Health Patients
Ziprasidone helps reduce hospitalizations for people with schizophrenia and bipolar disorder by improving symptom control without the weight gain or sedation of older antipsychotics. Studies show up to 45% fewer hospital admissions with consistent use.